Literature DB >> 8415873

Organophosphate poisoning.

T C Marrs.   

Abstract

The present review discusses the structure of the anticholinesterase organophosphates (OPs), which are used predominantly as insecticides. OP poisoning can occur in a variety of situations and can be accidental or suicidal. It is common in developing countries. The cholinergic syndrome is caused by acetylcholinesterase inhibition, and diagnosis is based on the clinical signs and symptoms as well as the measurement of inhibition of erythrocyte acetylcholinesterase and/or plasma cholinesterase activity. Antidotal treatment is with atropine, an enzyme reactivator such as pralidoxime and diazepam. Anticholinesterase OPs may produce effects other than the acute cholinergic syndrome, including the intermediate syndrome. Later effects may include organophosphorus-induced delayed neuropathy. Certain OPs are exploited for their anticholinesterase effects, including defoliants such as 'DEF', herbicides such as glyphosate, fire retardants and industrial intermediates. The toxicology of this group is heterogeneous and they may or may not possess anticholinesterase activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8415873     DOI: 10.1016/0163-7258(93)90066-m

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  63 in total

1.  Two step synthesis of a non-symmetric acetylcholinesterase reactivator.

Authors:  Kamil Musilek; Kamil Kuca; Vlastimil Dohnal; Daniel Jun; Jan Marek; Vit Koleckar
Journal:  Molecules       Date:  2007-08-07       Impact factor: 4.411

2.  Poisoning with Soman, an Organophosphorus Nerve Agent, Alters Fecal Bacterial Biota and Urine Metabolites: a Case for Novel Signatures for Asymptomatic Nerve Agent Exposure.

Authors:  Derese Getnet; Aarti Gautam; Raina Kumar; Allison Hoke; Amrita K Cheema; Franco Rossetti; Caroline R Schultz; Rasha Hammamieh; Lucille A Lumley; Marti Jett
Journal:  Appl Environ Microbiol       Date:  2018-10-17       Impact factor: 4.792

Review 3.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

Review 4.  Clinical applications of commonly used contemporary antidotes. A US perspective.

Authors:  C A Bowden; E P Krenzelok
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

5.  Why does the G117H mutation considerably improve the activity of human butyrylcholinesterase against sarin? Insights from quantum mechanical/molecular mechanical free energy calculations.

Authors:  Yuan Yao; Junjun Liu; Chang-Guo Zhan
Journal:  Biochemistry       Date:  2012-10-23       Impact factor: 3.162

6.  Cholinergic Crisis Caused by Cholinesterase Inhibitors: a Retrospective Nationwide Database Study.

Authors:  Hiroyuki Ohbe; Taisuke Jo; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  J Med Toxicol       Date:  2018-06-15

7.  Impaired mitochondrial functions in organophosphate induced delayed neuropathy in rats.

Authors:  Anwar Masoud; Ravi Kiran; Rajat Sandhir
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

8.  Effect of several new and currently available oxime cholinesterase reactivators on tabun-intoxicated rats.

Authors:  Jana Zdarova Karasova; Jiri Kassa; Young-Sik Jung; Kamil Musilek; Miroslav Pohanka; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2008-11-14       Impact factor: 6.208

9.  A comparison of the neuroprotective efficacy of newly developed oximes (K117, K127) and currently available oxime (obidoxime) in tabun-poisoned rats.

Authors:  Jiri Kassa; Jana Zdarova Karasova; Kamil Musilek; Kamil Kuca; And Young-Sik Jung
Journal:  Toxicol Mech Methods       Date:  2009-03       Impact factor: 2.987

10.  Effect of seven newly synthesized and currently available oxime cholinesterase reactivators on cyclosarin-intoxicated rats.

Authors:  Jana Zdarova Karasova; Jiri Kassa; Kamil Musilek; Miroslav Pohanka; Ladislav Novotny; Kamil Kuca
Journal:  Int J Mol Sci       Date:  2009-07-07       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.